Canada· CA-DIN-00886858

EMLA CREAM

A prilocain, kombinationen product containing prilocaine + lidocaine, registered in Canada by ASPEN PHARMACARE CANADA INC.. The same ATC class is registered in 7 of our 19 countries.

ATC N01BB54

Checked against Health Canada Drug Product Database (Canada) on

Informational only — not a medical device.

SOURCE REGISTER · CAHealth Canada Drug Product Database (Ca…normalisedEMLA CREAMATCN01BB54REGISTER NO.CA-DIN-00886858PACKS LISTED0CHECKEDOctober 1, 2026

Where it is registered

Prilocain, kombinationen is registered in 7 of 19 countries.

Countries holding a registration under ATC N01BB54 (prilocain, kombinationen), each read from that country’s own register.

  • This record: Canada, from Health Canada Drug Product Database (Canada)
  • 3 of them publish a price we can compare per daily dose

Prilocain, kombinationen · ATC N01BB54

7 / 19 countries

  • Canada
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Health Canada Drug Product Database (Canada)
Active substance
PRILOCAINE + LIDOCAINE
Manufacturer
ASPEN PHARMACARE CANADA INC.
Country
Canada (CA)
ATC code
N01BB54
ATC class
Prilocain, Kombinationen
Reimbursed
Not published by this register
Source register
Health Canada Drug Product Database (Canada)
Last checked
October 1, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Prilocain, kombinationen in 14 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All prilocain, kombinationen products

Authorised across Europe · EMA

The same active substance is authorised in 26 EEA countries. Names it is sold under:

  • Austria · Emla, Emla Pflaster
  • Belgium · Emla, Emla Patch
  • Cyprus · Emla, Xylocream
  • Czechia · Emla
  • Germany · Anesderm, Emla
  • Denmark · Emla, Lidocain/Prilocain Idd
  • Estonia · Nulbia
  • Spain · Anamap®, Anestderma
  • Finland · Emla, Oraqix
  • France · Anesderm, Emla
  • United Kingdom (Northern Ireland) · Emla, Nulbia
  • Greece · Emla, Nulbia
  • Hungary · Li-Pri
  • Ireland · Emla, Oraqix
  • Iceland · Emla, Fortacin
  • Italy · Emla, Lidocaina E Prilocaina Teva
  • Liechtenstein · Fortacin
  • Luxembourg · Emla, Emla Patch
  • Malta · Emla, Opralix
  • Netherlands · Emla, Lidocaïne/Prilocaïne Teva
  • Norway · Emla, Fortacin
  • Poland · Anesderm, Emla
  • Portugal · Emla, Emla Penso
  • Romania · Romla
  • Sweden · Emla, Oraqix
  • Slovakia · Romla

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Health Canada Drug Product Database (Canada). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/7ac0bd5f-8515-4edf-9a33-b7cde4c79a2a
GET /v1/drugs/7ac0bd5f-8515-4edf-9a33-b7cde4c79a2a?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "din": "00886858",
  "form": "CREAM",
  "class": "Human",
  "routes": [
    "TOPICAL"
  ],
  "source": "health_canada_dpd",
  "status": "MARKETED",
  "atc_raw": "N01BB54",
  "schedule": [
    "Ethical"
  ],
  "drug_code": "11440",
  "strengths": [
    "2.5 %"
  ],
  "ahfs_class": null,
  "substances": [
    "PRILOCAINE",
    "LIDOCAINE"
  ],
  "product_categorization": null
}

See everything about prilocain, kombinationen.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.